Manufacturer record

Torque Phamrmaceuticals Pvt. Ltd.13B-14: regulatory record

Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

1 batch manufactured by Torque Phamrmaceuticals Pvt. Ltd.13B-14 was declared Not of Standard Quality in February 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Most recent flagged batch: B46826001, Diphenhydramine Hydrochloride, Ammonium Chloride, Sodium Citrate and Terpin Hydrate Syrup (exp Dec 2027). RDTL, Chandigarh (CDSCO lab) found it not of standard quality: The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Sodium Citrate. Listed in the February 2026 alert.

Records by type

1 record linked to Torque Phamrmaceuticals Pvt. Ltd.13B-14 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
1Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Feb 2026 to Feb 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

1
NSQ batches since 2026
1
Products affected
Assay
Most common failure
Feb 2026
Latest alert

Flagged batches per year

2026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Diphenhydramine Hydrochloride, Ammonium Chloride, Sodium Citrate and Terpin Hydrate Syrup Batch B46826001Mfg Jan 2026 · Exp Dec 2027 The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Sodium Citrate.Assay RDTL, ChandigarhCDSCO lab Feb 2026

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.